E-LIB Suche - Ergebnisse für: Elizabeth R. Plimack

1

Phase I LITESPARK-001 study of belzutifan for advanced soli..:

Jonasch, Eric ; Bauer, Todd M. ; Papadopoulos, Kyriakos P....
European Journal of Cancer. 196 (2024) - p. 113434 , 2024

Link: https://doi.org/10.1016/..

2

Validation of the Lung Immune Prognostic Index (LIPI) as a ..:

Carril-Ajuria, Lucia ; Lavaud, Pernelle ; Dalban, Cecile...
European Journal of Cancer. 204 (2024) - p. 114048 , 2024

Link: https://doi.org/10.1016/..

3

Epacadostat plus pembrolizumab versus placebo plus pembroli..:

Cicin, Irfan ; Plimack, Elizabeth R. ; Gurney, Howard...
BMC Cancer. 23 (2024) S1 - p. , 2024

Link: https://doi.org/10.1186/..

4

8 Nivolumab plus ipilimumab vs sunitinib for first-line tre..:

Atkins, Michael B ; Escudier, Bernard ; McDermott, David F...
The Oncologist. 29 (2024) Supplement_1 - p. S17-S18 , 2024

Link: https://doi.org/10.1093/..

5

Correlative Analysis of ATM, RB1, ERCC2, and FANCC Mutation..:

Plimack, Elizabeth R. ; Tangen, Catherine ; Plets, Melissa...
European Urology. , 2024

Link: https://doi.org/10.1016/..

6

Treatment-free survival outcomes from the phase II study of..:

Atkins, Michael B ; Jegede, Opeyemi A ; Haas, Naomi B...
Journal for ImmunoTherapy of Cancer. 12 (2024) 4 - p. e008293 , 2024

Link: https://doi.org/10.1136/..

7

Role of Gut Microbiome in Neoadjuvant Chemotherapy Response..:

Bukavina, Laura ; Ginwala, Rashida ; Eltoukhi, Mohamed...
Cancer Research Communications. 4 (2024) 6 - p. 1505-1516 , 2024

Link: https://doi.org/10.1158/..

8

Treatment-free survival and partitioned survival analysis o..:

Mantia, Charlene M ; Jegede, Opeyemi A ; Plimack, Elizabeth R...
Journal for ImmunoTherapy of Cancer. 12 (2024) 7 - p. e009495 , 2024

Link: https://doi.org/10.1136/..

9

Patients' Perceptions Regarding the Relevance of Items Cont..:

Bergerot, Cristiane Decat ; Malhotra, Jasnoor ; Bergerot, Paulo...
The Oncologist. 28 (2023) 6 - p. 494-500 , 2023

Link: https://doi.org/10.1093/..

10

Pembrolizumab Plus Axitinib Versus Sunitinib as First-line ..:

Plimack, Elizabeth R. ; Powles, Thomas ; Stus, Viktor...
European Urology. 84 (2023) 5 - p. 449-454 , 2023

Link: https://doi.org/10.1016/..

11

Corrigendum to "Pembrolizumab Plus Axitinib Versus Sunitini..:

Plimack, Elizabeth R. ; Powles, Thomas ; Stus, Viktor...
European Urology. , 2023

Link: https://doi.org/10.1016/..

12

LITESPARK-012: Pembrolizumab Plus Lenvatinib With or Withou..:

Choueiri, Toni K ; Powles, Thomas ; Voss, Martin H...
Future Oncology. 19 (2023) 40 - p. 2631-2640 , 2023

Link: https://doi.org/10.2217/..

13

Harnessing potent therapies with care: enfortumab vedotin p..:

Ghatalia, Pooja ; Plimack, Elizabeth R.
Nature Reviews Clinical Oncology. 20 (2023) 12 - p. 818-819 , 2023

Link: https://doi.org/10.1038/..

14

Neoadjuvant Chemotherapy with Accelerated Methotrexate, Vin..:

Hemenway, Gregory ; Lewis, Bianca ; Ghatalia, Pooja...
European Urology Oncology. 6 (2023) 4 - p. 431-436 , 2023

Link: https://doi.org/10.1016/..

15

Results From a Randomized Phase II Trial of Sunitinib and G..:

Carthon, Bradley C. ; Kim, Se Eun ; McDermott, David F....
Clinical Genitourinary Cancer. 21 (2023) 5 - p. 546-554 , 2023

Link: https://doi.org/10.1016/..